Daniel P Cahill

Daniel P Cahill

UNVERIFIED PROFILE

Are you Daniel P Cahill?   Register this Author

Register author
Daniel P Cahill

Daniel P Cahill

Publications by authors named "Daniel P Cahill"

Are you Daniel P Cahill?   Register this Author

100Publications

3881Reads

40Profile Views

Neurologic complications of melanoma.

Cancer 2020 Feb 14;126(3):477-486. Epub 2019 Nov 14.

Division of Medical Oncology and Neuro-Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32619DOI Listing
February 2020

Super-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-mutated Human Gliomas.

Radiology 2020 Jan 7:191529. Epub 2020 Jan 7.

From the A. A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, 149 13th St, Suite 2301, Charlestown, MA 02129 (X.L., B.S., B.T., O.C.A.); iCAD, Nashua, NH (K.J.); Departments of Neurosurgery (J.S., D.P.C.) and Neurology (J.D.), Massachusetts General Hospital, Boston, Mass; Department of Neurology, Brigham and Women's Hospital, Boston, Mass (T.T.B.); and Dana-Farber Cancer Institute, Boston, Mass (T.T.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2020191529DOI Listing
January 2020

In Reply: A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.

Neurosurgery 2019 11;85(5):E966

Divisions of Neuro-Oncology and Hematology/Oncology Departments of Medicine and Neurology Massachusetts General Hospital Cancer Center Harvard Medical School Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuros/nyz327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792074PMC
November 2019

Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations.

Cancer 2019 Sep 17;125(17):2910-2914. Epub 2019 Jul 17.

Divisions of Neuro-Oncology and Hematology/Oncology, Departments of Neurology and Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32197DOI Listing
September 2019

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.

Cell 2019 Aug 18;178(4):835-849.e21. Epub 2019 Jul 18.

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2019.06.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703186PMC
August 2019

Factors that modify the risk of intraoperative seizures triggered by electrical stimulation during supratentorial functional mapping.

Clin Neurophysiol 2019 Jun 23;130(6):1058-1065. Epub 2019 Mar 23.

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinph.2019.03.006DOI Listing
June 2019

Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study.

Oncologist 2019 03 10;24(3):402-413. Epub 2018 Aug 10.

Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519760PMC
March 2019

Extent of Resection Versus Molecular Classification: What Matters When?

Neurosurg Clin N Am 2019 Jan;30(1):95-101

Department of Neurosurgery, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nec.2018.08.006DOI Listing
January 2019

Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups.

J Neurooncol 2019 Jan 7;141(2):327-335. Epub 2018 Dec 7.

Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-018-03034-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924170PMC
January 2019

Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:133-145. Epub 2019 May 17.

1 Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_238353DOI Listing
January 2019

Updates in prognostic markers for gliomas.

Neuro Oncol 2018 11;20(suppl_7):vii17-vii26

Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article/20/suppl_7/v
Publisher Site
http://dx.doi.org/10.1093/neuonc/noy158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225747PMC
November 2018

TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.

Acta Neuropathol Commun 2018 10 17;6(1):106. Epub 2018 Oct 17.

Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, 55 Fruit street, Boston, MA, USA.

View Article

Download full-text PDF

Source
https://actaneurocomms.biomedcentral.com/articles/10.1186/s4
Publisher Site
http://dx.doi.org/10.1186/s40478-018-0613-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193287PMC
October 2018

TERT Alterations in Progressive Treatment-Resistant Meningiomas.

Neurosurgery 2018 09;65(CN_suppl_1):66-68

Translational Neuro-Oncology Labora-tory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuros/nyy154DOI Listing
September 2018

Malignant Melanoma Metastatic to Oligodendroglioma: Case Report and Literature Review of Tumor-to-Tumor Metastasis to Gliomas.

J Neuropathol Exp Neurol 2018 07;77(7):549-554

Department of Neurosurgery at Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnen/nly029DOI Listing
July 2018

Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate.

Nat Commun 2018 04 16;9(1):1474. Epub 2018 Apr 16.

Department of Neurology, Massachusetts General Hospital, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Division of Hematology/Oncology, Harvard Medical School, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-03905-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902553PMC
April 2018

Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas.

Pharmacol Ther 2018 02 19;182:70-79. Epub 2017 Aug 19.

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01637258173021
Publisher Site
http://dx.doi.org/10.1016/j.pharmthera.2017.08.006DOI Listing
February 2018

Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.

Cancer 2017 Dec 5;123(23):4535-4546. Epub 2017 Oct 5.

Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31039DOI Listing
December 2017

Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma.

Cancer Cell 2017 10 28;32(4):411-426.e11. Epub 2017 Sep 28.

The David H. Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2017.08.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929990PMC
October 2017

IDH1 Mutation and World Health Organization 2016 Diagnostic Criteria for Adult Diffuse Gliomas: Advances in Surgical Strategy.

Neurosurgery 2017 09;64(CN_suppl_1):134-138

Department of Neurosurgery, Massac-husetts General Hospital Cancer Cen-ter, Harvard Medical School, Boston, Ma-ssachusetts.

View Article

Download full-text PDF

Source
http://academic.oup.com/neurosurgery/article/64/CN_suppl_1/1
Publisher Site
http://dx.doi.org/10.1093/neuros/nyx247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407733PMC
September 2017

Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas.

J Neurosurg 2017 08 25;127(2):438-444. Epub 2016 Nov 25.

Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2016.8.JNS161076DOI Listing
August 2017

Reply to Freyschlag et al.

Neuro Oncol 2017 04;19(4):598-599

Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (D.P.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now296DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464303PMC
April 2017

Treatment of brain metastases in the modern genomic era.

Pharmacol Ther 2017 02 20;170:64-72. Epub 2016 Oct 20.

Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States; Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2016.10.011DOI Listing
February 2017

The effect of IDH1 mutation on the structural connectome in malignant astrocytoma.

J Neurooncol 2017 02 15;131(3):565-574. Epub 2016 Nov 15.

Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 431, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2328-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377918PMC
February 2017

Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance.

Cell Stem Cell 2017 02 15;20(2):233-246.e7. Epub 2016 Dec 15.

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.stem.2016.11.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291795PMC
February 2017

Treatment of Adult Lower-Grade Glioma in the Era of Genomic Medicine.

Am Soc Clin Oncol Educ Book 2016 ;35:75-81

From the University of California, San Francisco, San Francisco, CA; Harvard Medical School, Boston, MA; Toronto General Hospital/Research Institute, Toronto, Canada; University of Maryland, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_158869DOI Listing
January 2017

Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection.

Neuro Oncol 2016 12 30;18(12):1656-1663. Epub 2016 Aug 30.

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (J.S.W., K.R.N); Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas (G.R.); Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (D.P.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744240PMC
December 2016

Case 38-2016. A 52-Year-Old Woman with Recurrent Oligodendroglioma.

N Engl J Med 2016 12;375(24):2381-2389

From the Departments of Neurology (A.S.C.), Neurosurgery (D.P.C.), Radiology (M.L.), and Pathology (D.N.L.), Massachusetts General Hospital, and the Departments of Neurology (A.S.C.), Neurosurgery (D.P.C.), Radiology (M.L.), and Pathology (D.N.L.), Harvard Medical School - both in Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcpc1610101DOI Listing
December 2016

Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients.

Neuro Oncol 2016 11 5;18(11):1569-1578. Epub 2016 Jul 5.

Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (K.J.-K., W.B., B.R.R., O.C.A.); Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (F.L., D.P.C.); Department of Neurosurgery, Charité Medical University, Berlin, Germany (F.L.); High Field MR Center, Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, Vienna, Austria (W.B.); Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (O.R., G.R.G.); Pappas Center of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G., A.S.C., T.T.B.); Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (J.U., H.A.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063518PMC
November 2016

A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.

Neuro Oncol 2016 09 6;18(9):1278-87. Epub 2016 Mar 6.

Department of Neurosurgery (F.N., S.-i.E., M.H., N.L., D.P.C., S.D.R., R.L.M., H.W.), Center for Human Genetic Research (M.F.J., V.R.), Department of Neuropathology (A.S.-R.), Division of Neuro-Oncology (P.K.B.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998993PMC
September 2016

Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma.

Clin Cancer Res 2016 Sep 13;22(17):4452-65. Epub 2016 Apr 13.

Department of Neurosurgery, Translational Neuro-Oncology Laboratory, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010492PMC
September 2016

Impact of histopathological transformation and overall survival in patients with progressive anaplastic glioma.

J Clin Neurosci 2016 Sep 6;31:99-105. Epub 2016 Jun 6.

Stephen E. and Catherine Pappas Center for Neuro-Oncology and Division of Hematology/Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, 55 Fruit Street/Y9E, Boston, MA 02114, USA; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S096758681600123
Publisher Site
http://dx.doi.org/10.1016/j.jocn.2016.02.019DOI Listing
September 2016

Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1.

CNS Oncol 2015 6;4(5):287-94. Epub 2015 Nov 6.

Southern Alberta Cancer Research Institute, University of Calgary, Calgary, AB T2N 1N4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns.15.32DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082339PMC
August 2016

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.

J Natl Cancer Inst 2016 Feb 23;108(2). Epub 2015 Oct 23.

Department of Medicine (PKB, RS), Department of Neurology (PKB, CMG), Department of Neurosurgery (GMS, PJ, BN, DPC, WTC, FGB), Department of Surgical Oncology (DTF), Department of Pathology (GG, DNL), Cancer Center (PKB, CMG, NN, DNL), Department of Radiology (JR) Massachusetts General Hospital, Harvard Medical School, Boston, MA; Broad Institute (ATW, GG), Department of Pathology, (MA, SS) and Department of Neurosurgery, Brigham and Women's Hospital (IFD), Boston, MA; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (DJP).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv310DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862417PMC
February 2016

Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma.

Oncologist 2016 Feb 1;21(2):214-9. Epub 2016 Feb 1.

Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA Division of Hematology/Oncology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746092PMC
February 2016

Glioblastoma care in the elderly.

Cancer 2016 Jan 30;122(2):189-97. Epub 2015 Nov 30.

Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29742DOI Listing
January 2016

Systemic therapy of brain metastases.

Curr Neurol Neurosci Rep 2015 ;15(2):518

Department of Radiation Oncology, Queen's University, Kingston, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11910-014-0518-9DOI Listing
July 2015

Determining optimal treatment strategy for diffuse glioma: the emerging role of IDH mutations.

Expert Rev Anticancer Ther 2015 Jun 17;15(6):603-6. Epub 2015 May 17.

University Hospital Carl Gustav Carus, Neurosurgery, Dresden University of Technology, Fetscherstrasse 74, D-01307, Dresden, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089964PMC
http://dx.doi.org/10.1586/14737140.2015.1047351DOI Listing
June 2015

Management of brain metastases in the era of targeted and immunomodulatory therapies.

Oncology (Williston Park) 2015 Apr;29(4):261-3

View Article

Download full-text PDF

Source
April 2015

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.

J Neurooncol 2015 Feb 20;121(3):557-63. Epub 2014 Nov 20.

Stephen E. and Catherine Pappas Center for Neuro-Oncology, Division of Hematology/Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Yawkey 9E, Boston, MA, 02114, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs11060-014-16
Web Search
http://link.springer.com/10.1007/s11060-014-1667-z
Publisher Site
http://dx.doi.org/10.1007/s11060-014-1667-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323868PMC
February 2015

Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.

Clin Cancer Res 2014 Jun 8;20(11):2898-909. Epub 2014 Apr 8.

Authors' Affiliations: Department of Neurosurgery; Division of Hematology/Oncology, Department of Neurology, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Translational Research Laboratory; Department of Pathology; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge; Translational Neuro-Oncology Laboratory; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Vesalius Research Center, VIB and Department of Oncology, KU Leuven, Leuven, BelgiumAuthors' Affiliations: Department of Neurosurgery; Division of Hematology/Oncology, Department of Neurology, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Translational Research Laboratory; Department of Pathology; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge; Translational Neuro-Oncology Laboratory; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Vesalius Research Center, VIB and Department of Oncology, KU Leuven, Leuven, BelgiumAuthors' Affiliations: Department of Neurosurgery; Division of Hematology/Oncology, Department of Neurology, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Translational Research Laboratory; Department of Pathology; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge; Translational Neuro-Oncology Laboratory; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; Vesalius Research Center, VIB and Department of Oncology, KU Leuven, Leuven, Belgium

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070445PMC
June 2014

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.

Science 2014 Jun 12;344(6190):1396-401. Epub 2014 Jun 12.

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. Broad Institute of Harvard and Massachusetts Institute of Techonology (MIT), Cambridge, MA 02142, USA. Howard Hughes Medical Institute Chevy Chase, MD 20815, USA.

View Article

Download full-text PDF

Source
http://www.sciencemag.org/cgi/doi/10.1126/science.1254257
Publisher Site
http://dx.doi.org/10.1126/science.1254257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123637PMC
June 2014

Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.

Cell 2014 Apr 10;157(3):580-94. Epub 2014 Apr 10.

Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2014.02.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004670PMC
April 2014

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection.

Neuro Oncol 2014 Jan 4;16(1):81-91. Epub 2013 Dec 4.

Corresponding author: Daniel P. Cahill, MD, PhD, Department of Neurosurgery, 32 Fruit Street - Yawkey 9E, Massachusetts General Hospital, Brain Tumor Center/Neuro-Oncology, Boston, MA 02114.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870823PMC
January 2014

Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management.

Oncology (Williston Park) 2013 Jun;27(6):504-14

Divisions of Neuro-Oncology and Hematology/Oncology, Department of Neurology, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital Cancer Center; Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
June 2013

Predictors of survival in contemporary practice after initial radiosurgery for brain metastases.

Int J Radiat Oncol Biol Phys 2013 Mar 14;85(3):656-61. Epub 2012 Aug 14.

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2012.05.047DOI Listing
March 2013

From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma.

Neurosurg Focus 2013 Feb;34(2):E2

Departments of Neurosurgery, Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2012.12.FOCUS12355DOI Listing
February 2013

Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes.

J Neurooncol 2012 Sep 18;109(3):555-63. Epub 2012 Jul 18.

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, 1400 Holcombe Blvd., Unit 442, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0926-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992290PMC
September 2012